Suppression of the Ewing’s sarcoma phenotype by FLI1/ERF repressor hybrids

[1]  P. Sorensen,et al.  Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein , 1999, Nature Genetics.

[2]  M. Roussel,et al.  Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity , 1999, Oncogene.

[3]  C. Denny,et al.  Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells , 1999, Oncogene.

[4]  H. Kovar,et al.  Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family. , 1999, Human pathology.

[5]  H. Kovar,et al.  The Ewing family of tumors and the search for the Achilles' heel. , 1999, Current opinion in oncology.

[6]  D. Sgouras,et al.  Transcriptional Repressor ERF Is a Ras/Mitogen-Activated Protein Kinase Target That Regulates Cellular Proliferation , 1999, Molecular and Cellular Biology.

[7]  P. Sorensen,et al.  EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Ladanyi,et al.  Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. , 1999, Cancer research.

[9]  S. Welford,et al.  EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction , 1998, Oncogene.

[10]  H. Kovar,et al.  Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. , 1998, Current opinion in oncology.

[11]  B. Wasylyk,et al.  Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. , 1998, Trends in biochemical sciences.

[12]  A. Nordheim,et al.  Ets transcription factors and human disease. , 1998, Biochimica et biophysica acta.

[13]  Olivier Delattre,et al.  EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes , 1998, Molecular and Cellular Biology.

[14]  R Berger,et al.  A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.

[15]  A. E. Sippel,et al.  DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI. , 1997, Nucleic acids research.

[16]  P. Defossez,et al.  Structure-function relationships of the PEA3 group of Ets-related transcription factors. , 1997, Biochemical and molecular medicine.

[17]  Marcienne M Wright,et al.  EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic , 1997, Nature Genetics.

[18]  K. Tanaka,et al.  EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. , 1997, The Journal of clinical investigation.

[19]  D. Blair,et al.  Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  H. Hurst.  Transcription factors as drug targets in cancer. , 1996, European journal of cancer.

[21]  P. Chambon,et al.  hTAF(II)68, a novel RNA/ssDNA‐binding protein with homology to the pro‐oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. , 1996, The EMBO journal.

[22]  T. Golub,et al.  Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia , 1996, Molecular and cellular biology.

[23]  M. Schemper,et al.  EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  J. Hata,et al.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. , 1996, Biochemical and biophysical research communications.

[25]  A. Bernstein,et al.  An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes , 1995, Molecular and cellular biology.

[26]  R. J. Fisher,et al.  ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets‐associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. , 1995, The EMBO journal.

[27]  M. Ouchida,et al.  Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. , 1995, Oncogene.

[28]  G. Thomas,et al.  Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.

[29]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Riegman,et al.  Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. , 1995, Oncogene.

[31]  C. Denny,et al.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. , 1995, Oncogene.

[32]  R. Meadows,et al.  Solution structure of the ets domain of Fli-1 when bound to DNA , 1994, Nature Structural Biology.

[33]  R. Fisher,et al.  Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis. , 1994, Oncogene.

[34]  P. Sorensen,et al.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.

[35]  C. Denny,et al.  The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.

[36]  J. Testa,et al.  The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[37]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[38]  R. Fisher,et al.  High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif. , 1991, Oncogene.

[39]  A. Bernstein,et al.  Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. , 1991, Genes & development.

[40]  B. Lewin.  Oncogenic conversion by regulatory changes in transcription factors , 1991, Cell.

[41]  J. Yee,et al.  Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. , 1989, Virology.

[42]  R. Mulligan,et al.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Miller,et al.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.

[44]  C. Denny,et al.  Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor. , 1997, Current topics in microbiology and immunology.

[45]  M. Klemsz,et al.  The ETS oncogene family in development, proliferation and neoplasia. , 1994, International journal of hematology.